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Poster Presentations: P2 P429segmentation. The current study hence aimed to determine whether choice
of ADNI MPRAGE acquisition and RF coil impacts on the compatibility of
common brain segmentation software packages.Methods: 3D T1-weighted
images of 9 subjects were acquired on a 3T GE MR750 scanner using 8, 12
and 32-channel coils (ADNI-1 MPRAGE, ADNI-GO/2 MPRAGE, ADNI-
GO/2 accelerated MPRAGE, together with a FSPGR volume for compari-
son). Images were processed using SPM-8, FSL and FreeSurfer in order
to determine grey matter (GM), white matter (WM) and cerebrospinal fluid
(CSF) volumes. Volumes were analysed in SPSS using the Intra-class corre-
lation co-efficient (ICC) as a reliability measure to examine how strongly
volumes between each coil and sequencewere related.Results:On average,
brain segmentation results using the ADNI-1MPRAGEwere the most com-
parable for GM using the 8(GM¼0.93), 12(GM¼0.88) and 32-
channel(GM¼0.87) coil, whereas the ADNI-GO-ACC sequence was most
comparable for WM: 8(0.99), 12(0.99) and 32-channel(0.97) coil. No
ADNI sequence was better than the others for segmenting CSF. Overall,
the 8-channel coil produced the most consistent GM andWM segmentation:
8(GM¼0.91,WM¼0.97), 12(GM¼0.88,WM¼0.92) and 32-channel
(GM¼0.76,WM¼0.91) coil. CSF segmentation using SPM-8(0.89) and
FSL(0.89) was best using the 8-channel coil, but overall FreeSurfer
segmentation using the 32-channel coil was the most comparable. Segmen-
tation reproducibility on average across all sequences was consistently
higher using FreeSurfer(GM¼0.87,WM¼0.95), compared to SPM-
8(GM¼0.84,WM¼0.92) and FSL(GM¼0.83,WM¼0.93). Conclusions:
Segmentation comparability was dependent on tissue type and was most
comparable in SPM-8, FSL and FreeSurfer in the following order:
WM>GM>CSF. Comparability for FreeSurfer and the ADNI-1 sequence
was best in both GM and WM. We have shown the extent to which
the choice of coil, sequence and brain segmentation software impacts thevol-
umetric analysis of MRI data. This has implications for future study design
and for initiatives aiming to combining multiple retrospective MRI studies.
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Background: Cognitive complaints are common in older adults includ-
ing controls with generally intact psychometric performance (HC) as
well as those with early or late mild cognitive impairment (EMCI,
LMCI). We analyzed the relationships between imaging biomarkers,
clinical performance, and cognitive complaints on the Measurement of
Everyday Cognition (E-Cog) from both the participant and his or her in-
formant in the ADNI-2 cohort. Methods: Data from 895 participants
were analyzed (256 HC, 287 EMCI, 210 LMCI, 142 AD). Measures
of amyloid deposition, glucose metabolism, and brain atrophy from tar-get regions of interest (ROIs) were extracted from Florbetapir PET, flu-
orodeoxyglucose (FDG) PET, and structural MRI, respectively. PET
scans were processed using standard techniques to generate SUVR mea-
sures intensity normalized to the whole cerebellum (Florbetapir) and
pons (FDG). MRI scans were analyzed using Freesurfer (R0Is) and
SPM8 (voxel based morphometry). Clinical, diagnostic, CSF, and cogni-
tive performance data was also obtained for all available participants at
the first ADNI-GO/2 visit. Associations between amyloid deposition,
glucose metabolism, brain atrophy, CSF A b and tau levels, cognitive
performance, and the extent of cognitive complaints on the E-Cog
from the participant and informant were assessed. Results: Diagnostic
groups differed in E-Cog scores for both participants and informants
as expected (Table 1), with greater complaints in the MCI and AD
groups. Significant associations between E-Cog self and informant mea-
sures and cognitive performance, amyloid deposition, glucose metabo-
lism, CSF A b and tau, and brain atrophy were also observed across
the full sample and within diagnostic groups (Figure 1). Generally, infor-
mant E-Cog scores in the memory domain and across all cognitive do-
mains showed more significant associations with biomarkers and
clinical performance than self-ratings by the participant. A notable ex-
ception was depressive symptoms which were more significantly associ-
ated with self E-Cog scores than informant scores. Conclusions:
Informant ratings of cognitive decline in mildly impaired and cognitively
healthy participants are better predictors of cognitive performance
and AD biomarker status than self-reported cognitive complaints. For
very early detection of incipient cognitive decline in secondary preven-
tion trials it may be advisable to ascertain informant ratings of
apparently healthy older adults and not only in those suspected of
MCI or dementia.
